Bio-Gene Technology Ltd. ( ($AU:BGT) ) has shared an announcement. Bio-Gene Technology Limited reported significant progress in Q1 FY26, including ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

Samsung is proceeding with an investment in U.S.-based Abe BioTechnologies (Abe Bio), a company specializing in gene editing ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within ...

Metagenomi announces successful integration of large genes in human cells using a novel, compact CAST system for potential therapeutic applications. Metagenomi, Inc., a precision genetic medicines ...

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...

The government’s long-promised Gene Technology Bill, which aims to reform laws around genetic modification, has run into a ...